AB079. SOH22ABS128. Receptor change on residual disease following neoadjuvant therapies for locally advanced breast cancer fails to impact oncological and survival outcomes

Rionagh Lynch,Matthew Davey, Siobhan Connolly, Tim Harding,Karl Sweeney, Carmel Malone,Michael Barry,Ray McLaughlin, Aoife Lowery, Michael Kerin

Mesentery and Peritoneum（2022）

引用 0|浏览2

暂无评分

摘要

Background: Conventional breast cancer patient management involves prescription of neoadjuvant therapies (NAT). The aim of this study was to evaluate the rate of receptor status change following NAT and to determine the impact of these changes on oncological and survival outcomes.

查看译文

关键词

neoadjuvant therapies,advanced breast cancer,breast cancer,receptor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要